AI assistant
Sending…
Citi Pharma Ltd. — Director's Dealing 2025
May 19, 2025
71782_rns_2025-05-19_3b77b33e-62bb-4ddb-b680-ce4a13ad0c03.pdf
Director's Dealing
Open in viewerOpens in your device viewer
| DISCLOSURE OF INTEREST BY RELEVANT PERSONS HOLDING COMPANY'S SHARES UNDER PSX REGULATION 5.6.4. | |||||||
| Details of Transactions | |||||||
| Sr. | Name of Relevant Person(s) with Description |
Form of Share |
Market | Date | Nature | **No. of Share(s) ** | Rate |
| 1 | AteeqUr Rehman | CDC | Through CDC | 15-Apr-25 | GIFT IN | 1,318,268 | 0 |
| 2 | Naveed Amjad | CDC | Through CDC | 15-Apr-25 | GIFT IN | 659,134 | 0 |
| 3 | Saima Usman | CDC | Through CDC | 15-Apr-25 | GIFT IN | 329,567 | 0 |
| 4 | Misbah Tahir | CDC | Through CDC | 15-Apr-25 | GIFT IN | 329,567 | 0 |
| 5 | Saad Bin Nadeem | CDC | Through CDC | 15-Apr-25 | GIFT IN | 22,850,000 | 0 |
| 6 | Saima Usman | CDC | Through CDC | 15-Apr-25 | GIFT IN | 2,700,000 | 0 |
| 7 | Misbah Tahir | CDC | Through CDC | 15-Apr-25 | GIFT IN | 2,700,000 | 0 |
30,886,536
More from Citi Pharma Ltd.
Capital/Financing Update
2026
May 21
M&A Activity
2026
May 6
Interim / Quarterly Report
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Mar 3
Investor Presentation
2026
Feb 27
Regulatory Filings
2026
Feb 26
Investor Presentation
2026
Feb 20
Interim / Quarterly Report
2026
Feb 18
Interim / Quarterly Report
2026
Feb 13